BioForce Nanosciences Holdings Inc
BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It also sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www… Read more
BioForce Nanosciences Holdings Inc (BFNH) - Total Liabilities
Latest total liabilities as of September 2025: $500.72K USD
Based on the latest financial reports, BioForce Nanosciences Holdings Inc (BFNH) has total liabilities worth $500.72K USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
BioForce Nanosciences Holdings Inc - Total Liabilities Trend (2002–2024)
This chart illustrates how BioForce Nanosciences Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
BioForce Nanosciences Holdings Inc Competitors by Total Liabilities
The table below lists competitors of BioForce Nanosciences Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Austral Gold Limited
PINK:AGLDF
|
USA | $100.69 Million |
|
Garibaldi Resources Corp
PINK:GGIFF
|
USA | $3.07 Million |
|
Afcon Holdings Ltd
TA:AFHL
|
Israel | ILA1.41 Billion |
|
Park Street A/S
CO:PARKST-A
|
Denmark | Dkr1.50 Billion |
|
Zenith Steel Pipes & Industries Limited
NSE:ZENITHSTL
|
India | ₹2.57 Billion |
|
AcouSort AB
ST:ACOU
|
Sweden | Skr3.21 Million |
|
Thai Wire Products Public Company Limited
BK:TWP
|
Thailand | ฿462.44 Million |
|
Finlay Minerals Ltd
OTCQB:FYMNF
|
USA | $3.96 Million |
Liability Composition Analysis (2002–2024)
This chart breaks down BioForce Nanosciences Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 638.68 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BioForce Nanosciences Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BioForce Nanosciences Holdings Inc (2002–2024)
The table below shows the annual total liabilities of BioForce Nanosciences Holdings Inc from 2002 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $2.30 Million | +26.52% |
| 2023-12-31 | $1.82 Million | +35.00% |
| 2022-12-31 | $1.35 Million | +54.41% |
| 2021-12-31 | $873.01K | +118.38% |
| 2020-12-31 | $399.77K | +3350.19% |
| 2019-12-31 | $11.59K | +117.68% |
| 2018-12-31 | $5.32K | -58.11% |
| 2017-12-31 | $12.71K | -10.03% |
| 2016-12-31 | $14.12K | +2724.60% |
| 2015-12-31 | $500.00 | 0.00% |
| 2014-12-31 | $500.00 | +100.00% |
| 2013-12-31 | $250.00 | -100.85% |
| 2012-12-31 | $-29.31K | -103.42% |
| 2008-12-31 | $858.09K | 0.00% |
| 2007-12-31 | $858.09K | -23.32% |
| 2006-12-31 | $1.12 Million | -15.91% |
| 2005-12-31 | $1.33 Million | +64.84% |
| 2004-12-31 | $807.32K | +39.21% |
| 2003-12-31 | $579.95K | +151.00% |
| 2002-12-31 | $231.06K | -- |